abstract |
The invention relates to compounds of formula (I), wherein R, X, R <SUP>1</SUP>, R<SUP>2</SUP>,R<SUP>3</SUP>, R<SUP>4</SUP> and R<SUP>5</SUP> have the significances specified in claim 1, wherein said compounds are embodied in the form of CHK1- CHK2- and SGK kinase inhibitors and can be used, inter alia, for treating cancer. |